Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic · Injection

Clindamycin 150 mg/mL injection price what pharmacies pay, and what you should

There is no weekly pharmacy acquisition cost for clindamycin 150 mg/ml injection this week. The makers, package codes, recalls and label are below.

What did you pay for clindamycin 150 mg/ml injection? Share it.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Supply status: shortages & recalls

In shortage27 products are short or being discontinued
12 ongoing recalls49 recalls on record, latest Sep 9, 2026

Shortages

  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)Sandoz Inc. · Available · Updated Nov 9, 2026Civica Label
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)Sandoz Inc. · Available · Updated Nov 9, 2026Civica Label
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)Sagent Pharmaceuticals · Limited Availability · Reason: Discontinuation of the manufacture of the drug · Updated Nov 6, 2026Selling through remaining short-dated inventory (Dec 2026).
  • Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)Sagent Pharmaceuticals · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 6, 2026Discontinuation of the manufacture of the drug
  • Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)Sagent Pharmaceuticals · Limited Availability · Reason: Discontinuation of the manufacture of the drug · Updated Nov 6, 2026Selling through remaining short-dated inventory (Dec 2026).
  • Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)Baxter Healthcare · Unavailable · Reason: Other · Updated Nov 3, 2026Estimated recovery: January 2027

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 49 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

Every manufacturer and package code

1 company sell clindamycin 150 mg/ml injection under 1 package code (NDC).

MakerPack sizesPackage codesPer unit
Medical Purchasing Solutions, LLC171872-7199-1 -
All 1 package codes

A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.

Other clindamycin strengths and forms

Strength and formPer unitPharmacies pay4 weeks52 weeks
75 mg capsule$0.2692$8.08 / 30 capsules+4.1%-10.6%
150 mg capsule$0.1048$3.14 / 30 capsules+1.9%-2.4%
300 mg capsule$0.1786$5.36 / 30 capsules+2.3%-1.7%
0.01 mg/mg gel$0.1362$8.17 / 60 g+4.2%-10.8%
0.01 mg/mg gel$3.63$271.89 / 75 mL+6.6%-54.7%
150 mg/mL, 2 mL injectionNot priced this week
150 mg/mL, 4 mL injectionNot priced this week
150 mg/mL, 6 mL injectionNot priced this week
10 mg/mL lotion$0.2323$13.94 / 60 mL-5.1%-26.6%
15 mg/mL oral solution$0.1328$13.28 / 100 mL+3.1%-19.5%
10 mg/mL topical foam$1.78$89.22 / 50 g-2.5%-38.8%
10 mg/mL topical solution$0.1892$11.35 / 60 mL+5.8%-22.9%
20 mg/mL vaginal cream$1.87$74.65 / 40 g+0.4%+19.0%

Official label & what changed

Last changedJuly 10, 2026
Version22 of 15
EffectiveJul 8, 2026
Read the label

Clindamycin Hydrochloride Capsules, USP

This drug has a boxed warning

WARNING

Clostridioides difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including clindamycin hydrochloride and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon, leading to overgrowth of

C. difficile.

Because clindamycin hydrochloride therapy has been associated with severe colitis which may end fatally, it should be reserved for serious infections where less toxic antimicrobial agents are inappropriate, as described in the

INDICATIONS AND USAGE section. It should not be used in patients with nonbacterial infections such as most upper respiratory tract infections.

C. difficileproduces toxins A and B, which contribute to the development of CDAD. Hypertoxin producing strains of

C. difficilecause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibacterial drug use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.

If CDAD is suspected or confirmed, ongoing antibacterial drug use not directed against

C. difficilemay need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibacterial drug treatment of

C. difficile, and surgical evaluation should be instituted as clinically indicated.

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Questions about clindamycin 150 mg/ml injection

Who makes clindamycin 150 mg/ml injection?

1 company: Medical Purchasing Solutions, LLC. See every package code.

Is clindamycin in shortage?

Yes - 27 products are listed as short or being discontinued. Details.

Has clindamycin been recalled?

49 recalls on record, 13 ongoing. Recalls name specific lots - check yours.

What does "pharmacies pay" mean?

It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.

Talk about clindamycin 150 mg/ml injection

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.